Internal compliance reviews are not enough; life sciences companies need to assess their third-party business partners
Yogesh Bahl, AlixPartners, LLP
Advertisement
Articles by Yogesh Bahl, AlixPartners, LLP
Advertisement
Latest Updated Articles
- Managing third-party risks in the life sciences industry
Published: January 27th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
Strive Pharmacy Breaks Ground on Arizona HQ
3
What MFN Pricing Means for Future Drug Development
4
Cencora Accelerates Global 3PL Expansion With Major Investments in Cold Chain and Specialty Logistics
5
